17β-estradiol and inflammation: Implications for ischemic stroke

Aging and Disease

Volumn 5, Issue 5, 2014, Pages 340-345

  Petrone, Ashley B ^a   Simpkins, James W ^a   Barr, Taura L ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Estrogen; Immune response; Inflammation; Ischemia; Neuroprotection; Stroke

Indexed keywords

EID: 84916929057     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500340     Document Type: Review

References (42)

1. Deb P, Sharma S, Hassan KM (2010). Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology, 17(3):197-218.
2. Mattson MP. Apoptosis in neurodegenerative disorders (2000). Nat Rev Mol Cell Biol., 1(2):120-129.
3. Iadecola C, Anrather J (2011). The immunology of stroke: from mechanisms to translation. Nat Med., 17(7):796-808.
4. Wang Q, Tang XN, Yenari MA (2007). THE INFLAMMATORY RESPONSE IN STROKE. J Neuroimmunol., 184(1-2):53-68.
5. Kamel H, Iadecola C (2012). Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol., 69(5):576-581.
6. Ritzel RM, Capozzi LA, McCullough LD (2013). Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav., 63(2):238-253.
7. Appelros P, Stegmayr B, Terént A (2009). Sex Differences in Stroke Epidemiology A Systematic Review. Stroke, 40(4):1082-1090.
8. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2013). Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation, 127(1):e6-e245.
9. De Leciñana MA, Egido JA, Fernández C, Martínez-Vila E, Santos S, Morales A, Martínez E, Pareja A, Alvarez-Sabín J, Casado I, PIVE Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group (2007). Risk of ischemic stroke and lifetime estrogen exposure. Neurology, 68(1):33-38.
10. Manthey D, Behl C (2006). From structural biochemistry to expression profiling: neuroprotective activities of estrogen. Neuroscience, 138(3):845-850.
11. Gustafsson J-Å (2003). What pharmacologists can learn from recent advances in estrogen signalling. Trends in Pharmacological Sciences, 24(9):479-485.
12. Hall JM, Couse JF, Korach KS (2001). The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling. J Biol Chem., 276(40):36869-36872.
13. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson J-A (2007). Estrogen receptors: how do they signal and what are their targets. Physiol Rev, 87(3):905-931.
14. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL (1997). Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg, 87(5):724-730.
15. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM (1998). Estradiol protects against ischemic injury. J Cereb Blood Flow Metab, 18(11):1253-1258.
16. Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD (1999). 17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals. Stroke, 30(8):1665-1670.
17. Zhang Y, Tounekti O, Akerman B, Goodyer CG, LeBlanc A (2001). 17-beta-estradiol induces an inhibitor of active caspases. J Neurosci., 21(20):RC176.
18. Yang SH, Shi J, Day AL, Simpkins JW (2000). Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke, 31(3):745-749.
19. Shughrue PJ, Lane MV, Merchenthaler I (1997). Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol., 388(4):507-525.
20. Dubal DB, Wise PM (2001). Neuroprotective Effects of Estradiol in Middle-Aged Female Rats. Endocrinology, 142(1):43-48.
21. Gibson CL, Gray LJ, Murphy SP, Bath PMW (2006). Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab, 26(9):1103-1113.
22. Harukuni I, Hurn PD, Crain BJ (2001). Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia. Brain Res, 900(1):137-142.
23. Leon RL, Li X, Huber JD, Rosen CL (2012). Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17β-estradiol. Endocrinology,153(7):3386-3393.
24. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SAA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, 291(14):1701-1712.
25. Lobo RA (2013). Where are we 10 years after the Women's Health Initiative? J Clin Endocrinol Metab., 98(5):1771-1780.
26. Grodstein F, Manson JE, Stampfer MJ, Rexrode K (2008). Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med., 168(8):861-866.
27. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE (2003). Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology, 144(5):2055-2067.
28. Brailoiu E, Dun SL, Brailoiu GC, Mizuo K, Sklar LA, Oprea TI, Prossnitz ER, Dun NJ (2007). Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol, 193(2):311-321.
29. Wang R, Zhang Q-G, Han D, Xu J, Lü Q, Zhang G-Y (2006). Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats. J Neurochem, 99(6):1543-1554.
30. Choi YC, Lee JH, Hong KW, Lee KS (2004). 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam Clin Pharmacol, 18(5):547-557.
31. Singer CA, Rogers KL, Dorsa DM (1998). Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport, 9(11):2565-2568.
32. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM (1999). Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci., 19(15):6385-6393.
33. Alkayed NJ, Goto S, Sugo N, Joh HD, Klaus J, Crain BJ, Bernard O, Traystman RJ, Hurn PD (2001). Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci., 21(19):7543-7550.
34. Stoltzner SE, Berchtold NC, Cotman CW, Pike CJ (2001). Estrogen regulates bcl-x expression in rat hippocampus. Neuroreport, 12(13):2797-2800.
35. Rao AK, Dietrich AK, Ziegler YS, Nardulli AM (2011). 17β-Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia. J Steroid Biochem Mol Biol., 127(3-5):382-389.
36. Sung J-H, Cho E-H, Min W, Kim M-J, Kim M-O, Jung E-J, Koh P-O (2010). Identification of proteins regulated by estradiol in focal cerebral ischemic injury--a proteomics approach. Neurosci Lett., 477(2):66-71.
37. Rau SW, Dubal DB, Böttner M, Wise PM (2003). Estradiol differentially regulates c-Fos after focal cerebral ischemia. J Neurosci, 23(33):10487-10494.
38. Jia J, Guan D, Zhu W, Alkayed NJ, Wang MM, Hua Z, Xu Y (2009). Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp Neurol, 215(1):48-52.
39. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM (1999). The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci, 19(7):2455-2463.
40. Raz L, Zhang Q, Han D, Dong Y, De Sevilla L, Brann DW (2011). Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen. PLoS ONE, 6(10):e27039.
41. Nadkarni S, McArthur S (2013). Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity. Curr Opin Pharmacol., Aug;13(4):576-581.
42. Lakhan SE, Kirchgessner A, Hofer M (2009). Inflammatory mechanisms in ischemic stroke: therapeutic approaches. Journal of Translational Medicine, 7(1):97.